Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
C$0.00
C$11.77
C$26.00
C$2.15BN/A229,895 shs4.61 million shs
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$15.19
$8.13
$19.08
$24.33M0.4122,224 shs237,144 shs
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
$0.38
$0.38
$0.26
$1.30
$67.96M0.747,701 shs29,889 shs
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$1.15
+3.6%
$0.66
$0.35
$1.95
$1.22B1.8576.17 million shs51.16 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
0.00%0.00%0.00%0.00%+29.93%
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
0.00%0.00%0.00%0.00%0.00%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
+3.60%+11.65%+56.23%+159.95%-39.15%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
N/AN/AN/AN/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2.6666 of 5 stars
3.11.00.00.03.81.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
0.00
N/AN/AN/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
0.00
N/AN/AN/A
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
0.00
N/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2.20
Hold$1.9266.67% Upside

Current Analyst Ratings Breakdown

Latest PYR, AUP, CARA, and TLRY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/29/2025
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
Zelman & Associates
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
C$57.59M0.00N/A6.75C$2.59 per share0.00
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$7.14M0.00N/AN/A$12.58 per share0.00
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
$14.63M4.65N/AN/A$0.07 per share5.43
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$821.31M1.54$0.15 per share7.68$1.40 per share0.82
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
N/A-C$1.48N/AN/AN/AN/AN/AN/AN/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
-$118.51M-$21.01N/AN/AN/A-1,099.76%-367.97%-107.43%N/A
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
-$24.74M-$0.11N/AN/A-233.18%-194.66%-68.91%N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$2.19B-$2.31N/AN/AN/A-265.69%-6.83%-5.45%10/9/2025 (Estimated)

Latest PYR, AUP, CARA, and TLRY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/28/2025Q4 2025
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$0.03$0.02+$0.05-$1.30$250.41 million$224.54 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
N/AN/AN/AN/AN/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
N/AN/AN/AN/AN/A
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
N/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
2.69
11.93
11.02
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
N/A
4.77
4.71
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
0.26
0.86
0.78
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.20
2.46
1.49

Institutional Ownership

CompanyInstitutional Ownership
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
N/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
44.66%
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
0.41%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
9.35%

Insider Ownership

CompanyInsider Ownership
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
N/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
3.10%
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
47.68%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurinia Pharmaceuticals Inc. stock logo
AUP
Aurinia Pharmaceuticals
300128.40 millionN/ANot Optionable
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
804.57 million4.43 millionOptionable
PyroGenesis Canada Inc. stock logo
PYR
PyroGenesis Canada
2,020178.88 million93.59 millionNot Optionable
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2,8421.10 billion1.09 billionOptionable

Recent News About These Companies

Tilray Brands (NASDAQ:TLRY) Trading Down 3.3% - Time to Sell?
Logo visible on smartphone screen with website page
Tilray's High Hopes: The Catalyst Driving Cannabis Stocks
...
Top Cannabis Stocks To Watch Today - August 20th
Tilray Brands (NASDAQ:TLRY) Trading Down 7.5% - Time to Sell?
Cannabis Stocks To Follow Today - August 19th
Tilray cannabis
Tilray Shares Blazing: What's Behind the 55% Rally This Month?
...
Tilray Brands (NASDAQ:TLRY) Shares Gap Up - Here's Why
Cannabis Stocks Worth Watching - August 16th
Best Canadian Cannabis Stocks in 2025
Best Cannabis Stocks To Follow Today - August 15th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aurinia Pharmaceuticals stock logo

Aurinia Pharmaceuticals TSE:AUP

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Cara Therapeutics stock logo

Cara Therapeutics NASDAQ:CARA

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

PyroGenesis Canada stock logo

PyroGenesis Canada NASDAQ:PYR

PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and solutions worldwide. It offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products; plasma atomization process that allows produce and sell high purity spherical metal powders; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP NSiR, which is designed to transform silicon into spherical silicon nano powders and nanowires for use in lithium-ion batteries. The company also provides plasma torches and plasma torch systems used toreplace fossil fuel burners in industrial iron ore pelletization process; plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. In addition, it offers engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Further, the company provides installation, commissioning, and start-up services. PyroGenesis Canada Inc. is headquartered in Montréal, Canada.

Tilray Brands stock logo

Tilray Brands NASDAQ:TLRY

$1.15 +0.04 (+3.60%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$1.14 0.00 (-0.43%)
As of 08/22/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.